Research & Development: Page 75
-
PharmaVoice Team/PharmaVoice
Table of Contents
In Every Issue 3 Letter from the Editor 8 Upfront A brief review of industry news at press time 34 PharmaOutlet Kit Howard looks at what makes professional certification valuable. 36 PharmaTrax Sales, marketing, and R&D trends from industry analysts 38 What’s New New healthcare-related produc...
By PharmaVoice Team • March 25, 2009 -
PharmaVoice Team/PharmaVoice
Last Word
Novartis Oncology’s David Epstein discusses the growing relevance of diagnostics in drug development. Mr. Epstein credits breakthroughs in biology and bioinformatics with an increased understanding of the genome that will enable developers to do a better job of matching the right drug with the ri...
By PharmaVoice Team • March 25, 2009 -
Explore the Trendline➔
Stock via Getty Images
TrendlineBig Pharma Business Strategies
Large pharmas are consistently tasked with the goal of growth. But in recent years, the upward trajectory has been littered with new hurdles.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
E-Media
New electronic and web-based applications, sites, and technologies Knexus Provides Business-to-Business Social Media Platform Knexus Tech has introduced a business-to-business (B2B) social media platform that gives companies a quick, easy way to engage busy business professionals with quality ins...
By PharmaVoice Team • March 25, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, marketing, And R&D Trends affecting the healthcare industry Verified Physicians Ensure Quality Data As online physician panels gain popularity among pharmaceutical and medical device companies that conduct Web-based surveys, research shows there is little interest in verifying that the...
By PharmaVoice Team • March 25, 2009 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Kit Howard, M.S., CCDM, CRCP What makes professional certification valuable? In recent years, there has been a proliferation of certification programs within the pharma/biotech/devices world. Some are broad-based, such as project management (e.g., the Project Management Institute’s...
By Kit Howard • March 25, 2009 -
PharmaVoice Team/PharmaVoice
UpFront
Investment Portfolio R&D Spending by U.S. Biopharmaceutical Companies Increases 3% in 2008 A new report reveals that R&D investment in new medicines by the biopharmaceutical industry was $65.2 billion in 2008, an increase of 3% from 2007, according to a combined analysis conducted by Burr...
By PharmaVoice Team • March 25, 2009 -
PharmaVoice Team/PharmaVoice
Advair: The Drug to Watch
The inhaler is well on its way to blockbuster status in the U.S., where it debuted in April 2001. Advair Diskus already is the fastestgrowing asthma medicine in Europe, where it is marketed under the name Seretide, and Goldman Sachs analysts fore cast that global sales of the drug will reach $2.4...
By Lynda Sears • March 17, 2009 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES ePocrates To Collaborate With Express Scripts on HANDHELD FORMULARY INITIATIVE ePocrates has agreed to incorporate the formu lary information of Express Scripts Inc., a national pharmacy benefits manager, into the ePocrates Rx Form...
By PharmaVoice Team • March 11, 2009 -
PharmaVoice Team/PharmaVoice
What's New
Ventiv Health Inc., MDS Pharma Services,and Paul Capital Partners have joined forces to provide lifesci ences companies with a broad range of development, commercialization,and investment support. The alliance combines the drug discovery and development expertise of MDS Pharma Services,the commer...
By PharmaVoice Team • March 11, 2009 -
PharmaVoice Team/PharmaVoice
Defining GLOBAL
BY DENISE MYSHKO AND ROBIN ROBINSON KARLA ANDERSON Managing Director, Life Sciences BearingPoint Global is a perspective of looking at the business in its totality, not just at a given market or a given country or a given set of rules and regulations, but at the business as a whole. It’s always c...
By Denise Myshko and Robin Robinson • March 1, 2009 -
PharmaVoice Team/PharmaVoice
Global Thought leaders
Karla Anderson, Managing Director, Life Sciences, BearingPoint Inc. — A provider of management and technology consulting services. For more information, visit bearingpoint.com. Leone Atkinson, M.D., Senior Director of Clinical Development, PTC Therapeutics Inc. — A biopharmaceutical company focus...
By PharmaVoice Team • Feb. 27, 2009 -
PharmaVoice Team/PharmaVoice
An Approach to Language in GLOBAL Trials
Informed consent procedure requires that written consent be translated into the patient’s native language, and any unique cultural aspects be taken into account. In addition, many countries have multiple language translation requirements, depending on the population demographics. When linguistic ...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
GLOBAL Patient Recruitment
BY DENISE MYSHKO Patient recruitment has and will continue to evolve in a global marketplace, with all countries competing equally and being measured on performance for the quality of patients screened and recruited within the shortest amount of time. “The U.S. market was the most developed in te...
By Denise Myshko • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
GLOBAL Talent
As companies globalize and seek to maximize the opportunities and challenges that result, they need to ensure that they have an understanding of the talent potential that exists globally. All too often companies think in local operating terms or seek to attract talent within the country where the...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Deirdre CONNELLY GlaxoSmithKline Selects Head of North American Pharma Business Deirdre Connelly, former president of U.S. operations at Eli Lilly, has joined GlaxoSmithKline (GSK) as president, North American pharmaceuticals. Ms. Connelly was appointed president of U.S. opera...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
E-media
New electronic and web-based applications, sites, and technologies Ziment Unveils New Market Research Tool Ziment has introduced an analytic technique, SequenceZ, which allows forecasters to make better use of market research by providing more accurate assessments of the effect of product launch ...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
What's New
New healthcare-related products, services, and companies GfK Consolidates Market Research Operations Operating as one entity allows GfK Healthcare to pull together its strengths and individual leadership positions across multi-client research. The GfK U.S. Healthcare Companies has consolidated it...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, marketing, And R&D Trends affectinga the healthcare industry EU Candidate Countries Offer Ripe Field for Clinical-Trial Recruitment Conducting clinical trials in Europe is not a new concept for global pharmaceutical companies, but choosing the country in which to hold a particular tria...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
Upfront
Milestones kinetix turns 10 Kinetix, a specialized healthcare consulting firm that uses exclusive, proprietary communication channels to build and implement live and online marketing programs, is celebrating its 10th anniversary. Over the last 10 years, Kinetix has developed strategies to communi...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
Dr. Donald G. Payan — Reaching for the Stars Through Molecules
As cofounder, executive VP, and chief scientific officer of Rigel Pharmaceuticals, Dr. Donald G. Payan intends to have his company become the brightest star among those hunting for new drugs. LIFE’S BIGGEST DECISIONS OFTEN CAN BE ATTRIBUTED TO COINCIDENCE. In the mid-1960s, Dr. Payan arrived in C...
By Taren Grom • Feb. 23, 2009 -
PharmaVoice Team/PharmaVoice
Addressing Pharma's $40 Billion Challenge
Addressing Pharma’s $40 Billion Challenge With A MAJOR GAP IN ITS PIPELINE of potential replacement blockbusters, the pharmaceutical industry is FACING A CRISIS. IN AN EXCLUSIVE TO PHARMAVOICE, MICHAEL PERRY, PH.D., PRESIDENT AND CEO OF PHARSIGHT CORP., AND ARTHUR REIDEL, CHAIRMAN OF THE BOARD OF...
By PharmaVoice Team • Feb. 23, 2009 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEB-BASED APPLICATIONS, SITES, AND TECHNOLOGIES PatientLinx.com Offers NEWS UPDATES BY DISEASE AND THERAPEUTIC CATEGORIES MDLinx has launched PatientLinx.com, a free Website that provides reliable clinical updates for patients. PatientLinx aggregates research by disease and the...
By PharmaVoice Team • Feb. 23, 2009 -
PharmaVoice Team/PharmaVoice
What's New
NEW HEALTHCARE-RELATED PRODUCTS, SERVICES, AND COMPANIES NOP World Health Forms a New Division to RESPOND TO PHARMACEUTICAL PUBLIC-RELATIONS CRISES Through a combination of in-depth therapeutic class analyses, events-driven Web research, and multi-stake holder image tracking and reputation assess...
By PharmaVoice Team • Feb. 22, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
SALES, MARKETING, AND R&D TRENDS AFFECTING THE HEALTHCARE INDUSTRY GENERICS SECTOR Expected to Double by 2007 According to Datamonitor, by 2007 the generics market is expected to be valued at $57 billion, more than twice its estimated value of $27 billion in 2001. Researchers at the company c...
By PharmaVoice Team • Feb. 22, 2009 -
PharmaVoice Team/PharmaVoice
Raise Your Voice: Letters
LETTERS Two critical areas of success Missed Opportunities Your article on “The Patient Pipeline” highlighted many of the difficulties in patient accrual and retention. Unfortunately the solutions in my opinion missed two critical success factors. As CEO and cofounder of MCSI, the largest U.S.-b...
By PharmaVoice Team • Feb. 22, 2009
Previous
